Cargando…
Optimizing hepatitis C virus treatment through pharmacist interventions: Identification and management of drug-drug interactions
AIM: To quantify drug-drug-interactions (DDIs) encountered in patients prescribed hepatitis C virus (HCV) treatment, the interventions made, and the time spent in this process. METHODS: As standard of care, a clinical pharmacist screened for DDIs in patients prescribed direct acting antiviral (DAA)...
Autores principales: | Langness, Jacob A, Nguyen, Matthew, Wieland, Amanda, Everson, Gregory T, Kiser, Jennifer J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5340814/ https://www.ncbi.nlm.nih.gov/pubmed/28321163 http://dx.doi.org/10.3748/wjg.v23.i9.1618 |
Ejemplares similares
-
Investigation of immune escape-associated mutations of hepatitis B virus in patients harboring hepatitis B virus drug-resistance mutations
por: Huang, Bi-Xia, et al.
Publicado: (2020) -
Clinical pharmacists’ involvement in carbapenem antibiotics management at Wenzhou Integrated Hospital
por: Xu, Xue-Mei, et al.
Publicado: (2023) -
Optimal treatment strategies for hepatic portal venous gas: A retrospective assessment
por: Gonda, Masanori, et al.
Publicado: (2020) -
Distribution and drug resistance of pathogenic bacteria in emergency patients
por: Huai, Wei, et al.
Publicado: (2019) -
Effects of different intervention methods on psychological flexibility, negative emotions and sleep quality in chronic hepatitis B
por: Zheng, Ying, et al.
Publicado: (2023)